Design and characterization of viral polypeptide inhibitors targeting Newcastle disease virus fusion

Journal of Molecular Biology

Volumn 354, Issue 3, 2005, Pages 601-613

  Zhu, Jieqing ^a,b,e   Jiang, Xiuli ^c,f   Liu, Yueyong ^a,b,d   Tien, Po ^a   Gao, George F ^a  

^a INSTITUTE OF MICROBIOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d ZHEJIANG UNIVERSITY   (China)

^e HARVARD MEDICAL SCHOOL   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Fusion; Heptad repeat (HR); Inhibitors design; Newcastle disease virus (NDV); Paramyxovirus

Indexed keywords

ANTIVIRUS AGENT; GLUTATHIONE TRANSFERASE; POLYPEPTIDE; PROTEIN 5 HELIX; PROTEIN GST 5 HELIX; PROTEIN GST HR121; PROTEIN GST HR212; PROTEIN HR1; PROTEIN HR121; PROTEIN HR2; PROTEIN HR212; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; VIRUS FUSION PROTEIN;

ARTICLE; BINDING ASSAY; CELL FUSION; CONTROLLED STUDY; DRUG DESIGN; DRUG PROTEIN BINDING; DRUG PURIFICATION; DRUG STABILITY; DRUG TARGETING; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION SYSTEM; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; NEWCASTLE DISEASE PARAMYXOVIRUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS STRAIN; VIRUS VIRULENCE;

ESCHERICHIA COLI; HUMAN IMMUNODEFICIENCY VIRUS; INFLUENZA VIRUS; NEWCASTLE DISEASE VIRUS; PARAMYXOVIRIDAE;

EID: 27744533984     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2005.08.078     Document Type: Article

References (33)

1. R.A. Lamb Paramyxovirus fusion: a hypothesis for changes Virology 197 1993 1 11
2. C.M. Horvath, and R.A. Lamb Studies on the fusion peptide of a paramyxovirus fusion glycoprotein: roles of conserved residues in cell fusion J. Virol. 66 1992 2443 2455
3. J.S. Kahn, M.J. Schnell, L. Buonocore, and J.K. Rose Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion Virology 254 1999 81 91
4. T.G. Morrison Structure and function of a paramyxovirus fusion protein Biochim. Biophys. Acta 1614 2003 73 84
5. K.A. Baker, R.E. Dutch, R.A. Lamb, and T.S. Jardetzky Structural basis for paramyxovirus-mediated membrane fusion Mol. Cell 3 1999 309 319
6. D.M. Eckert, and P.S. Kim Mechanisms of viral membrane fusion and its inhibition Annu. Rev. Biochem. 70 2001 777 810
7. R.A. Lamb, S.B. Joshi, and R.E. Dutch The paramyxovirus fusion protein forms an extremely stable core trimer: structural parallels to influenza virus haemagglutinin and HIV-1 gp41 Mol. Membr. Biol. 16 1999 1 19
8. X. Zhao, M. Singh, V.N. Malashkevich, and P.S. Kim Structural characterization of the human respiratory syncytial virus fusion protein core Proc. Natl Acad. Sci. USA 97 2000 14172 14177
9. J. Zhu, P. Li, T. Wu, F. Gao, Y. Ding, and C.W.-H. Zhang Design and analysis of post-fusion 6-helix bundle of heptad repeat regions from Newcastle disease virus F protein Protein Eng. 16 2003 373 379
10. J. Zhu, C.W.-H. Zhang, Y. Qi, P. Tien, and G.F. Gao The fusion protein core of measles virus forms stable coiled-coil trimer Biochem. Biophys. Res. Commun. 299 2002 897 902
11. J.Q. Zhu, C.W.-H. Zhang, Z. Rao, P. Tien, and G.F. Gao Biochemical and biophysical analysis of heptad repeat regions from the fusion protein of Menangle virus, a newly emergent paramyxovirus Arch. Virol. 148 2003 1301 1316
12. Y. Nagai, H.D. Klenk, and R. Rott Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus Virology 72 1976 494 508
13. Y. Nagai, N.M. Inocencio, and B. Gotoh Paramyxovirus tropism dependent on host proteases activating the viral fusion glycoprotein Behring Inst. Mitt. 1991 35 45
14. E. Wang, X. Sun, Y. Qian, L. Zhao, P. Tien, and G.F. Gao Both heptad repeats of human respiratory syncytial virus fusion protein are potent inhibitors of viral fusion Biochem. Biophys. Res. Commun. 302 2003 469 475
15. J.K. Young, R.P. Hicks, G.E. Wright, and T.G. Morrison Analysis of a peptide inhibitor of paramyxovirus (NDV) fusion using biological assays, NMR, and molecular modeling Virology 238 1997 291 304
16. J.K. Young, D. Li, M.C. Abramowitz, and T.G. Morrison Interaction of peptides with sequences from the Newcastle disease virus fusion protein heptad repeat regions J. Virol. 73 1999 5945 5956
17. M. Yu, E. Wang, Y. Liu, D. Cao, N. Jin, and C.W. Zhang Six-helix bundle assembly and characterization of heptad repeat regions from the F protein of Newcastle disease virus J. Gen. Virol. 83 2002 623 629
18. D.M. Eckert, and P.S. Kim Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region Proc. Natl Acad. Sci. USA 98 2001 11187 11192
19. M. Lu, S.C. Blacklow, and P.S. Kim A trimeric structural domain of the HIV-1 transmembrane glycoprotein Nature Struct. Biol. 2 1995 1075 1082
20. C. Wild, T. Oas, C. McDanal, D. Bolognesi, and T. Matthews A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition Proc. Natl. Acad. Sci. USA 89 1992 10537 10541
21. S.G. Peisajovich, and Y. Shai New insights into the mechanism of virus-induced membrane fusion Trends Biochem. Sci. 27 2002 183 190
22. J.P. Lalezari, K. Henry, M. O'Hearn, J.S. Montaner, P.J. Piliero, and B. Trottier Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America N. Engl. J. Med. 348 2003 2175 2185
23. J.M. Louis, C.A. Bewley, and G.M. Clore Design and properties of N(CCG)-gp41, a chimeric gp41 molecule with nanomolar HIV fusion inhibitory activity J. Biol. Chem. 276 2001 29485 29489
24. M.J. Root, M.S. Kay, and P.S. Kim Protein design of an HIV-1 entry inhibitor Science 291 2001 884 888
25. T.F. Wild, and R. Buckland Inhibition of measles virus infection and fusion with peptides corresponding to the leucine zipper region of the fusion protein J. Gen. Virol. 78 1997 107 111
26. S. Tong, and R.W. Compans Alternative mechanisms of interaction between homotypic and heterotypic parainfluenza virus HN and F proteins J. Gen. Virol. 80 1999 107 115
27. S.B. Joshi, R.E. Dutch, and R.A. Lamb A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41 Virology 248 1998 20 34
28. J. Stone-Hulslander, and T.G. Morrison Detection of an interaction between the HN and F proteins in Newcastle disease virus-infected cells J. Virol. 71 1997 6287 6295
29. R.K. Plemper, A.L. Hammond, D. Gerlier, A.K. Fielding, and R. Cattaneo Strength of envelope protein interaction modulates cytopathicity of measles virus J. Virol. 76 2002 5051 5061
30. L.W. McGinnes, K. Gravel, and T.G. Morrison Newcastle disease virus HN protein alters the conformation of the F protein at cell surfaces J. Virol. 76 2002 12622 12633
31. K.A. Gravel, and T.G. Morrison Interacting domains of the HN and F proteins of Newcastle disease virus J. Virol. 77 2003 11040 11049
32. B.J. Bosch, Z.R. van der, C.A. de Haan, and P.J. Rottier The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex J. Virol. 77 2003 8801 8811
33. J. Zhu, G. Xiao, Y. Xu, F. Yuan, C. Zheng, and Y. Liu Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein and identification of potent peptide inhibitors Biochem. Biophys. Res. Commun. 319 2004 15 20